NCT06703359 Predictive Properties of the 6-Minute Stepper Test for Mortality in COPD
| NCT ID | NCT06703359 |
| Status | Recruiting |
| Phase | — |
| Sponsor | ADIR Association |
| Condition | COPD |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2024-06-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Retrospective study aimed to answer the following research questions : * What are the predictive properties of the 6-minute stepper in COPD for 2-year mortality in individuals with COPD ? * What are the predictive properties of the 6-minute stepper in COPD for 5-year mortality in invididuals with COPD ?
Eligibility Criteria
Inclusion Criteria: * Age \> 18 years; * Covered by a social security scheme; * COPD (all stages); * Referred for pulmonary rehabilitation; * Completed a 6-Minute Stepper Test at the start of their program. Non-inclusion Criteria: * Patients under guardianship or legal supervision; * Pregnant or breastfeeding women. Exclusion Criteria: * Not applicable.
Contact & Investigator
Tristan Bonnevie, PhD
PRINCIPAL INVESTIGATOR
ADIR Association
Frequently Asked Questions
Who can join the NCT06703359 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying COPD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06703359 currently recruiting?
Yes, NCT06703359 is actively recruiting participants. Contact the research team at t.bonnevie@adir-hautenormandie.com for enrollment information.
Where is the NCT06703359 trial being conducted?
This trial is being conducted at Rouen, France.
Who is sponsoring the NCT06703359 clinical trial?
NCT06703359 is sponsored by ADIR Association. The principal investigator is Tristan Bonnevie, PhD at ADIR Association. The trial plans to enroll 250 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.